Consistency's UK team to cycle 1,200 miles for charity

23 September 2020 Consultancy.uk

This weekend, the UK team of management consulting firm Consistency will cycle 1,200 miles for charity. At time of writing, the consultants have raised almost £700 for cancer research.

One of the most popular forms of corporate social responsibility action in the consulting world is undisputedly the charity cycle ride. Seeing it as an opportunity to stay in shape, get some fresh air, and make the most of the all-too-brief British summer, consultants often jump at the chance of getting on their bikes in the name of a good cause. In the last two years, offices from across the UK have taken to the road from PwC, Mazars, CBRE, Mazars and many more have accrued thousands of miles of travel between them.

The latest of these efforts will see members of Consistency take to British roads in an effort to raise money for cancer research. Every day, one in five people in the UK is likely to be impacted by cancer, be it by being diagnosed, or by finding out a loved one has been. As a result, members of the UK wing of the German-origin consultancy have committed to take part in a marathon bicycle journey, to fundraise for Cancer Research UK.

Consistency's UK team to cycle 1,200 miles for charity

Colleagues from the UK – including UK Managing Director Sven Riedel and Consultant Jun Lin – are set to participate in the fundraising event ‘Bike to Beat Cancer,’ which will see them cycle a total of 1,200 miles to support the cause. The highlight will be a group ride from Oxford through the Cotswolds ending up in the West Midlands on the weekend of September 25-27.

Over the course of the efforts, Consistency staff will be cycling on their own and as teams, competing on mileage and having some fun along the way.

Speaking on his involvement in the event, Jun Lin said via his LinkedIn profile, “Ready to bag a few more miles today! Great cause and fantastic opportunity for a team building activity outdoors!”

At present, Consistency has raised £677 of its £800 target for the event, via its Cancer Research UK profile.